344 related articles for article (PubMed ID: 23159991)
1. Correlation between benign prostatic hyperplasia and inflammation.
Bostanci Y; Kazzazi A; Momtahen S; Laze J; Djavan B
Curr Opin Urol; 2013 Jan; 23(1):5-10. PubMed ID: 23159991
[TBL] [Abstract][Full Text] [Related]
2. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
3. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
[TBL] [Abstract][Full Text] [Related]
4. Could inflammation be a key component in the progression of benign prostatic hyperplasia?
Kramer G; Marberger M
Curr Opin Urol; 2006 Jan; 16(1):25-9. PubMed ID: 16385197
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
Fibbi B; Penna G; Morelli A; Adorini L; Maggi M
Int J Androl; 2010 Jun; 33(3):475-88. PubMed ID: 19508330
[TBL] [Abstract][Full Text] [Related]
6. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
Kramer G; Mitteregger D; Marberger M
Eur Urol; 2007 May; 51(5):1202-16. PubMed ID: 17182170
[TBL] [Abstract][Full Text] [Related]
7. HMGB1: a potential target for treatment of benign prostatic hyperplasia.
Rui X; Shengli M; Zhankui J; Guofu P; Jinjian Y
Med Hypotheses; 2013 Nov; 81(5):892-5. PubMed ID: 23948596
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress--cause or consequence of male genital tract disorders?
Kullisaar T; Türk S; Punab M; Mändar R
Prostate; 2012 Jun; 72(9):977-83. PubMed ID: 22025397
[TBL] [Abstract][Full Text] [Related]
9. [Inflammation and benign prostatic hyperplasia: cause or consequence?].
Robert G; Salagierski M; Schalken JA; de La Taille A
Prog Urol; 2010 Jun; 20(6):402-7. PubMed ID: 20538203
[TBL] [Abstract][Full Text] [Related]
10. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
11. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
[TBL] [Abstract][Full Text] [Related]
12. Benign prostatic hyperplasia: age-related tissue-remodeling.
Untergasser G; Madersbacher S; Berger P
Exp Gerontol; 2005 Mar; 40(3):121-8. PubMed ID: 15763388
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammation in benign prostatic hyperplasia: implications for therapy.
Wang L; Yang JR; Yang LY; Liu ZT
Med Hypotheses; 2008; 70(5):1021-3. PubMed ID: 17935901
[TBL] [Abstract][Full Text] [Related]
14. The role of prostatic inflammation in the development and progression of benign and malignant diseases.
Gandaglia G; Zaffuto E; Fossati N; Cucchiara V; Mirone V; Montorsi F; Briganti A
Curr Opin Urol; 2017 Mar; 27(2):99-106. PubMed ID: 27906778
[TBL] [Abstract][Full Text] [Related]
15. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Chiang BJ; Kuo HC; Liao CH
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
[TBL] [Abstract][Full Text] [Related]
16. Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
Lloyd GL; Marks JM; Ricke WA
Curr Urol Rep; 2019 Aug; 20(9):54. PubMed ID: 31377881
[TBL] [Abstract][Full Text] [Related]
17. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi?
Kim SH; Jung KI; Koh JS; Min KO; Cho SY; Kim HW
Urol Int; 2013; 90(2):144-9. PubMed ID: 23295780
[TBL] [Abstract][Full Text] [Related]
18. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.
Ficarra V; Rossanese M; Zazzara M; Giannarini G; Abbinante M; Bartoletti R; Mirone V; Scaglione F
Curr Urol Rep; 2014 Dec; 15(12):463. PubMed ID: 25312251
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
20. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
Pawlicki B; Zieliński H; Dabrowski M
Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]